ArticleAnnals of neurosciences2026
Improving Care Quality for Metabolic Dysfunction-associated Steatotic Liver Disease Through a Structured Yogic Intervention: Protocol for a Randomised Controlled Trial.
Article in Annals of neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world. It is strongly linked to obesity, high blood pressure, type 2 diabetes and dyslipidaemia. Yoga, which includes asanas, pranayama, shat-karmas and meditation, may offer a holistic approach to improve the liver, metabolism and mental health. Purpose: To evaluate the effectiveness of a 60-min yoga module in improving liver health and metabolic parameters in MASLD patients. Methods: This open-label, two-arm, randomised controlled trial enrolled 72 adults aged 18-60 years diagnosed with MASLD, who received standard care at a hospital in Dehradun. Participants were randomised equally into a yoga group, which received a 60-min online yoga module 5 days per week for 3 months, or a control group receiving standard treatment alone. Key assessments include ultrasound measurement of liver fat, liver enzymes (serum glutamate pyruvate transaminase [SGPT], serum glutamic-oxaloacetic transaminase [SGOT]), HbA1c, lipid profile, body mass index, blood pressure, mental health and quality of life. Data collection occurred at baseline and 3 months post-intervention. Results: The study is designed to assess improvements in hepatic steatosis and metabolic and psychosocial parameters following intervention. Conclusion: This trial will provide evidence on the role of yoga as an adjunct therapy in MASLD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.